牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

恩威医药（301331）

3.8

综合诊断：3.8分打败了11%的股票！

卖出
减持
中性
增持
买入

短期趋势：
市场最近连续上涨中，短期小心回调。
中期趋势：
-
长期趋势：
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

1.4分

3.1分

6.6分

3.1分

5.8分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：1.4技术面打败了2%的股票技术面评分前10的股票

近期的平均成本为49.74元，股价在成本上方运行。

技术面得分最高的股票

平均成本

近期的平均成本为49.74元，股价在成本上方运行。

[{"text":"\u5e73\u5747\u6210\u672c","value":"49.74","date":1664439641,"color":"0x9f0ba1"}]

市场表现

该股为新上市股票，上市以来表现良好，呈上升趋势。

[{"date":"2022.09.30","stock":"6.57","trade":"2.05","ind":"-1.29"},{"date":"2022.09.29","stock":"-17.96","trade":"-0.29","ind":"0.18"},{"date":"2022.09.28","stock":"12.84","trade":"-1.09","ind":"-2.46"},{"date":"2022.09.27","stock":"16.20","trade":"4.25","ind":"1.94"},{"date":"2022.09.26","stock":"4.85","trade":"-2.59","ind":"-0.40"},{"date":"2022.09.23","stock":"9.37","trade":"-1.49","ind":"-0.97"},{"date":"2022.09.22","stock":"-12.85","trade":"-2.04","ind":"-0.84"},{"date":"2022.09.21","stock":"46.74","trade":"-0.16","ind":"-0.67"},{"date":"2022.09.20","stock":false,"trade":"1.44","ind":"0.69"},{"date":"2022.09.19","stock":false,"trade":"-1.64","ind":"-0.48"},{"date":"2022.09.16","stock":false,"trade":"-3.10","ind":"-2.30"},{"date":"2022.09.15","stock":false,"trade":"-1.57","ind":"-2.10"},{"date":"2022.09.14","stock":false,"trade":"-0.58","ind":"-1.25"},{"date":"2022.09.13","stock":false,"trade":"0.97","ind":"0.38"},{"date":"2022.09.09","stock":false,"trade":"0.82","ind":"1.11"},{"date":"2022.09.08","stock":false,"trade":"-0.69","ind":"-0.86"},{"date":"2022.09.07","stock":false,"trade":"-0.75","ind":"0.42"},{"date":"2022.09.06","stock":false,"trade":"1.15","ind":"1.04"},{"date":"2022.09.05","stock":false,"trade":"-0.68","ind":"-0.20"},{"date":"2022.09.02","stock":false,"trade":"0.47","ind":"-0.09"},{"date":"2022.09.01","stock":false,"trade":"0.52","ind":"-0.88"}]

恩威医药,深证成指,中药指数

压力支撑

该股压力位为48.37元，支撑位为43.51元。

[{"text":"\u538b\u529b\u4f4d","value":"48.37","date":1664467200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"43.51","date":1664467200,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了23%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

上市8日来，主力建仓行为不明显，尚未控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：10月06日 20:32

机构今日流向(万元)	1379.36	机构5日流向(万元)	2603.94
机构10日流向(万元)	-934.93	机构20日流向(万元)	-5829.02

消息面诊股

诊断结果：6.6消息面打败了93%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

利好	业绩预告	业绩预盈	2022-09-02
一般消息	募资投向		2022-09-01

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：3.1行业面打败了46%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2022.09.30","price":"-1.29","value":"2.05"},{"date":"2022.09.29","price":"0.18","value":"-0.29"},{"date":"2022.09.28","price":"-2.46","value":"-1.09"},{"date":"2022.09.27","price":"1.94","value":"4.25"},{"date":"2022.09.26","price":"-0.40","value":"-2.59"},{"date":"2022.09.23","price":"-0.97","value":"-1.49"},{"date":"2022.09.22","price":"-0.84","value":"-2.04"},{"date":"2022.09.21","price":"-0.67","value":"-0.16"},{"date":"2022.09.20","price":"0.69","value":"1.44"},{"date":"2022.09.19","price":"-0.48","value":"-1.64"},{"date":"2022.09.16","price":"-2.30","value":"-3.10"},{"date":"2022.09.15","price":"-2.10","value":"-1.57"},{"date":"2022.09.14","price":"-1.25","value":"-0.58"},{"date":"2022.09.13","price":"0.38","value":"0.97"},{"date":"2022.09.09","price":"1.11","value":"0.82"},{"date":"2022.09.08","price":"-0.86","value":"-0.69"},{"date":"2022.09.07","price":"0.42","value":"-0.75"},{"date":"2022.09.06","price":"1.04","value":"1.15"},{"date":"2022.09.05","price":"-0.20","value":"-0.68"},{"date":"2022.09.02","price":"-0.09","value":"0.47"},{"date":"2022.09.01","price":"-0.88","value":"0.52"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	康缘药业	998.33%	1.38%	6.1分
2	康跃科技	166.30%	0.00%	3.6分
3	陇神戎发	43.06%	2.32%	3.8分
4	-	4.39%	4.39%	分
5	同仁堂	1.65%	5.00%	5.6分
6	云南白药	0.73%	0.67%	5.1分
7	济川药业	-0.17%	3.81%	6.1分
8	方盛制药	-0.17%	8.23%	5.4分
9	汉森制药	-1.24%	5.47%	5.0分
10	华润三九	-1.97%	9.68%	6.1分
11	以岭药业	-2.16%	13.01%	5.9分
12	沃华医药	-2.23%	-4.67%	5.2分
13	紫鑫药业	-2.35%	7.79%	4.5分
14	龙津药业	-2.36%	10.58%	3.8分
15	桂林三金	-2.55%	3.33%	4.8分
16	信邦制药	-3.01%	5.68%	5.7分
17	葵花药业	-3.12%	4.46%	5.0分
18	众生药业	-3.24%	6.83%	5.3分
19	特一药业	-3.64%	2.55%	4.7分
20	康恩贝	-3.65%	1.02%	4.9分
21	昆药集团	-3.73%	-0.44%	5.1分
22	新光药业	-4.55%	2.83%	4.3分
23	金花股份	-4.58%	3.16%	5.1分
24	珍宝岛	-4.60%	0.77%	4.6分
25	千金药业	-4.77%	2.11%	5.1分
26	天士力	-4.78%	3.83%	4.9分
27	启迪药业	-4.85%	3.56%	4.7分
28	粤万年青	-4.87%	5.40%	3.9分
29	白云山	-4.94%	-0.04%	5.1分
30	益佰制药	-5.08%	2.23%	4.7分
31	华神科技	-5.11%	2.06%	4.6分
32	东阿阿胶	-5.24%	3.02%	5.0分
33	葫芦娃	-5.39%	2.20%	5.2分
34	益盛药业	-5.65%	0.94%	3.9分
35	西藏药业	-5.70%	3.37%	5.6分
36	嘉应制药	-5.89%	-0.80%	4.5分
37	上海凯宝	-6.13%	2.16%	4.8分
38	达仁堂	-6.15%	2.50%	5.0分
39	佐力药业	-6.47%	8.08%	5.7分
40	新天药业	-6.80%	4.71%	5.3分
41	贵州三力	-6.83%	0.53%	4.7分
42	维康药业	-7.01%	1.91%	3.9分
43	奇正藏药	-7.62%	-0.37%	4.7分
44	九芝堂	-8.10%	0.00%	4.5分
45	ST目药	-8.25%	-5.73%	4.5分
46	红日药业	-8.36%	4.99%	5.6分
47	精华制药	-8.55%	1.01%	4.9分
48	寿仙谷	-8.59%	2.74%	5.5分
49	羚锐制药	-9.28%	4.06%	5.5分
50	健民集团	-9.30%	1.09%	4.6分
51	太极集团	-9.32%	7.00%	5.7分
52	盘龙药业	-9.51%	3.83%	4.9分
53	马应龙	-9.70%	2.61%	4.9分
54	贵州百灵	-10.31%	-0.78%	4.3分
55	片仔癀	-10.56%	5.58%	4.9分
56	ST康美	-12.56%	-4.23%	4.5分
57	大理药业	-15.99%	1.49%	4.6分
58	ST太安	-18.99%	-17.53%	4.2分
59	莱茵生物	-19.32%	-5.13%	4.5分
60	-	-21.92%	-3.26%	分
61	康惠制药	-23.32%	-5.00%	4.4分
62	香雪制药	-47.60%	4.34%	3.7分
63	中恒集团	-1096.15%	-1.89%	3.5分
64	步长制药	-	0.86%	5.1分
65	广誉远	-	-2.14%	4.2分
66	江中药业	-	0.91%	4.5分
67	亚宝药业	-	-0.18%	4.3分
68	太龙药业	-	-0.95%	4.6分
69	恩威医药	-	20.20%	3.8分
70	*ST吉药	-	-11.71%	3.8分
71	华森制药	-	9.51%	4.6分
72	佛慈制药	-	0.22%	5.1分
73	万邦德	-	0.12%	4.0分
74	仁和药业	-	0.54%	4.6分
75	吉林敖东	-	-4.15%	3.8分

<上一页 1 2 3 4 5...13 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.8基本面打败了49%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值一般。

个股深一度

基本面得分最高的股票

[ 截止日期：2022-06-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/124 ， 43/124。

[{"date":"2022-06-30","value":"5.92","vol":"3.30"},{"date":"2022-03-31","value":"3.11","vol":"1.97"},{"date":"2021-12-31","value":"16.56","vol":"6.79"},{"date":"2021-09-30","value":"10.98","vol":"7.14"},{"date":"2021-06-30","value":"7.59","vol":"5.47"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
净资产收益率(%)	5.92	3.11	16.56	10.98	7.59
行业(%)	3.30	1.97	6.79	7.14	5.47

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"51.50","vol":"54.66"},{"date":"2022-03-31","value":"","vol":"54.23"},{"date":"2021-12-31","value":"56.34","vol":"54.90"},{"date":"2021-09-30","value":"","vol":"54.79"},{"date":"2021-06-30","value":"56.98","vol":"55.71"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
销售毛利率(%)	51.50	-	56.34	-	56.98
行业(%)	54.66	54.23	54.90	54.79	55.71

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 47/124 ， 45/124。

[{"date":"2022-06-30","value":"0.47","vol":"1.92"},{"date":"2022-03-31","value":"-3.93","vol":"3.18"},{"date":"2021-12-31","value":"7.18","vol":"11.85"},{"date":"2021-09-30","value":"9.22","vol":"17.66"},{"date":"2021-06-30","value":"","vol":"23.29"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
营业收入同比增长率(%)	0.47	-3.93	7.18	9.22	-
行业(%)	1.92	3.18	11.85	17.66	23.29

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"-11.91","vol":"-14.45"},{"date":"2022-03-31","value":"-7.25","vol":"-27.17"},{"date":"2021-12-31","value":"3.03","vol":"-83.73"},{"date":"2021-09-30","value":"7.60","vol":"247.58"},{"date":"2021-06-30","value":"","vol":"86.32"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
净利润同比增长率(%)	-11.91	-7.25	3.03	7.60	-
行业(%)	-14.45	-27.17	-83.73	247.58	86.32

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/124 ， 21/124。

[{"date":"2022-06-30","value":"0.38","vol":"0.26"},{"date":"2022-03-31","value":"0.18","vol":"0.13"},{"date":"2021-12-31","value":"0.79","vol":"0.55"},{"date":"2021-09-30","value":"0.58","vol":"0.41"},{"date":"2021-06-30","value":"0.40","vol":"0.28"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
总资产周转率(次)	0.38	0.18	0.79	0.58	0.40
行业(次)	0.26	0.13	0.55	0.41	0.28

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"1.52","vol":"1.32"},{"date":"2022-03-31","value":"","vol":"0.66"},{"date":"2021-12-31","value":"3.15","vol":"2.76"},{"date":"2021-09-30","value":"","vol":"1.96"},{"date":"2021-06-30","value":"1.74","vol":"1.35"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
存货增长率(次)	1.52	-	3.15	-	1.74
行业(次)	1.32	0.66	2.76	1.96	1.35

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/124 ， 36/124。

[{"date":"2022-06-30","value":"19.68","vol":"18.46"},{"date":"2022-03-31","value":"-2.79","vol":"7.17"},{"date":"2021-12-31","value":"12.60","vol":"11.48"},{"date":"2021-09-30","value":"-5.50","vol":"-8.64"},{"date":"2021-06-30","value":"23.81","vol":"22.20"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
现金流量净额/营业收入	19.68	-2.79	12.60	-5.50	23.81
行业	18.46	7.17	11.48	-8.64	22.20

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"0.79","vol":"1.71"},{"date":"2022-03-31","value":"","vol":"0.00"},{"date":"2021-12-31","value":"1.07","vol":"1.83"},{"date":"2021-09-30","value":"","vol":"0.00"},{"date":"2021-06-30","value":"0.95","vol":"2.06"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
资本支出／折旧和摊销	0.79	-	1.07	-	0.95
行业	1.71	0.00	1.83	0.00	2.06

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/124 ， 34/124。

[{"date":"2022-06-30","value":"2.44","vol":"2.87"},{"date":"2022-03-31","value":"","vol":"2.96"},{"date":"2021-12-31","value":"2.08","vol":"2.96"},{"date":"2021-09-30","value":"","vol":"2.99"},{"date":"2021-06-30","value":"1.80","vol":"2.99"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
流动比率	2.44	-	2.08	-	1.80
行业	2.87	2.96	2.96	2.99	2.99

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"1.69","vol":"2.16"},{"date":"2022-03-31","value":"","vol":"2.27"},{"date":"2021-12-31","value":"1.38","vol":"2.34"},{"date":"2021-09-30","value":"","vol":"2.32"},{"date":"2021-06-30","value":"1.26","vol":"2.33"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
速动比率	1.69	-	1.38	-	1.26
行业	2.16	2.27	2.34	2.32	2.33

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 48/124 ， 53/124。

[{"date":"2022-06-30","value":"23.15","vol":"33.87"},{"date":"2022-03-31","value":"24.50","vol":"32.82"},{"date":"2021-12-31","value":"26.10","vol":"33.23"},{"date":"2021-09-30","value":"27.53","vol":"33.65"},{"date":"2021-06-30","value":"28.77","vol":"33.95"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
资产负债率(%)	23.15	24.50	26.10	27.53	28.77
行业(%)	33.87	32.82	33.23	33.65	33.95

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2022-06-30","value":"0.30","vol":"0.81"},{"date":"2022-03-31","value":"0.32","vol":"0.71"},{"date":"2021-12-31","value":"0.35","vol":"0.70"},{"date":"2021-09-30","value":"0.38","vol":"0.62"},{"date":"2021-06-30","value":"0.40","vol":"0.62"}]

	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30
产权比率 (%)	0.30	0.32	0.35	0.38	0.40
行业(%)	0.81	0.71	0.70	0.62	0.62

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2022年的收益，请投资者后续关注。

[{"date":"2018","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.99","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[恩威医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]